Modular bioprocessing systems offer fast, efficient, flexible manufacturing. System “building blocks” (or, prefabricated single-use subassemblies) link together with sterile connection technologies. Regardless of size or configuration, all modular systems require reliable connectors to facilitate, protect, and manage fluid flow from the beginning of the process to final fill-and-finish.
CPC set the industry standard for modularity connection technologies with its AseptiQuik® Series connectors.
Typical processes may include dozens, or even hundreds, of connections. CPC’s biopharma fluid management expertise and innovative connector technology helps deliver key factors required for modular strategy success.
In this white paper, we review modular system strategy for biomanufacturing and the connector technology that enables it. Both modular and single-use systems present the means to reduce costs, increase productivity, improve quality, reduce risk, and increase flexibility in biopharmaceutical applications. Learn how by reading the article and clicking the button below.
In Episode 1, Todd Andrews, Director of Applications & Business Development in CPC Biopharma, invites Jay Harp, VP of Sales & Operations from Int2 Solutions to discuss all things modularity in bioprocess manufacturing.
Originally presented at BPI 2025, CPC Biotech's Maria Bollensen discusses how to mitigate risk using modular and single-use systems to reduce costs, increase productivity, improve quality, reduce risk, and increase flexibility in biopharmaceutical applications. Also, taking a deeper look at the new regulations supporting single-use technology; including BPOG guidelines, USP <665> and USP <383>.
In Episode 5, we have a guest host: Michael Francis sits down with Kevin de Jager of HITMA and discusses upcoming regulations shaping process manufacturing – specifically, Annex I and USP665.